# Umbilical-Cord-Derived Mesenchymal Stem Cells Injection for Chronic Radiation Proctitis

> **NCT06438809** · PHASE1,PHASE2 · RECRUITING · sponsor: **Jiangsu Topcel-KH Pharmaceutical Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Chronic Radiation Proctitis

## Interventions

- **BIOLOGICAL:** Mesenchymal Stem Cells (MSCs)

## Key facts

- **NCT ID:** NCT06438809
- **Lead sponsor:** Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-24
- **Primary completion:** 2025-05
- **Final completion:** 2025-05
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06438809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06438809, "Umbilical-Cord-Derived Mesenchymal Stem Cells Injection for Chronic Radiation Proctitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06438809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*